鲁抗医药(600789.SH)：上半年净利润1.07亿元 同比下降64.38%

Group 1 - The company reported a total operating revenue of 3.15 billion, representing a year-on-year decrease of 3.83% [1] - The net profit attributable to shareholders of the listed company was 107 million, showing a significant year-on-year decline of 64.38% [1] - The net profit attributable to shareholders after deducting non-recurring gains and losses was 100 million, indicating a year-on-year increase of 9.16% [1]